Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Rovin

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Kidney International|February 21, 2019
Citius, altius, fortius . . . . faster, higher, strongerPierre Ronco, Brad Rovin, , et al.
Toxicologic Pathology|October 4, 2018
Advances and Challenges on New Therapies and Clinical Targets of Acute Kidney InjuryRima Kang, Brad Rovin
Kidney International|July 6, 2016
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritisHans-Joachim Anders, Brad Rovin
The New England Journal of Medicine|February 3, 2009
Uric acid and cardiovascular riskLee A Hebert, Brad Rovin
Clinical Nephrology|May 23, 2014
Stable long-term renal function in a patient with κ-light chain renal tubular crystalline depositionMargaret Ryan, Brad Rovin, Tibor Nadasdy
Kidney International|July 1, 2025
Optimizing the use of anti-CD20 in childhood idiopathic nephrotic syndrome: an intersection of art and scienceEugene Yu-Hin Chan, Brad Rovin
Seminars in Nephrology|September 3, 2017
Introduction: Translational Immunology in Kidney DiseaseHans-Joachim Anders, David Jayne, Brad Rovin
Clinical Kidney Journal|September 29, 2015
Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicineHans-Joachim Anders, Marc Weidenbusch, Brad Rovin
The New England Journal of Medicine|January 22, 2015
Rituximab or azathioprine maintenance in ANCA-associated vasculitisLee A Hebert, Anthony Alvarado, Brad Rovin
Current Rheumatology Reports|February 28, 2019
Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis FlareIsabelle Ayoub, Dan Birmingham, Brad Rovin, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Kidney International|February 21, 2019
Citius, altius, fortius . . . . faster, higher, strongerPierre Ronco, Brad Rovin, , et al.
Toxicologic Pathology|October 4, 2018
Advances and Challenges on New Therapies and Clinical Targets of Acute Kidney InjuryRima Kang, Brad Rovin
Kidney International|July 6, 2016
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritisHans-Joachim Anders, Brad Rovin
The New England Journal of Medicine|February 3, 2009
Uric acid and cardiovascular riskLee A Hebert, Brad Rovin
Clinical Nephrology|May 23, 2014
Stable long-term renal function in a patient with κ-light chain renal tubular crystalline depositionMargaret Ryan, Brad Rovin, Tibor Nadasdy
Kidney International|July 1, 2025
Optimizing the use of anti-CD20 in childhood idiopathic nephrotic syndrome: an intersection of art and scienceEugene Yu-Hin Chan, Brad Rovin
Seminars in Nephrology|September 3, 2017
Introduction: Translational Immunology in Kidney DiseaseHans-Joachim Anders, David Jayne, Brad Rovin
Clinical Kidney Journal|September 29, 2015
Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicineHans-Joachim Anders, Marc Weidenbusch, Brad Rovin
The New England Journal of Medicine|January 22, 2015
Rituximab or azathioprine maintenance in ANCA-associated vasculitisLee A Hebert, Anthony Alvarado, Brad Rovin
Current Rheumatology Reports|February 28, 2019
Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis FlareIsabelle Ayoub, Dan Birmingham, Brad Rovin, et al.
Pageof 10